572
Views
10
CrossRef citations to date
0
Altmetric
Research Article

New perspective to develop memantine orally disintegrating tablet formulations: SeDeM expert system

, , , , , & show all
Pages 512-519 | Received 09 Mar 2017, Accepted 19 Jun 2017, Published online: 18 Jul 2017

References

  • Aguilar-Díaz JE, Garcia-Montoya E, Pérez-Lozano P, Suñe-Negre JM, Miñarro M, Ticó JR. 2009. The use of the SeDeM diagram expert system to determine the suitability of diluents–disintegrants for direct compression and their use in formulation of ODT. Eur J Pharm Biopharm. 73:414–423.
  • Aguilar-Díaz JE, Garcia-Montoya E, Suñe-Negre JM, Pérez-Lozano P, Miñarro M, Ticó JR. 2012. Predicting orally disintegrating tablets formulations of ibuprophen tablets: an application of the new SeDeM-ODT expert system. Eur J Pharm Biopharm. 80:638–648.
  • Aguilar-Díaz JE, García-Montoya E, Pérez-Lozano P, Suñé-Negre JM, Miñarro M, Ticó JR. 2014. SeDeM expert system a new innovator tool to develop pharmaceutical forms. Drug Dev Ind Pharm. 40:222–236.
  • Bandari S, Mittapalli RK, Gannu R, Rao YM. 2008. Orodispersible tablets: an overview. Asian J Pharm. 2:2–11.
  • Bassil N, Thaipisuttikul P, Grossberg GT. 2010. Memantine ER, a once-daily formulation for the treatment of Alzheimer’s disease. Expert Opin Pharmacother. 11:1765–1771.
  • Bi YX, Sunada H, Yonezawa Y, Danjo K. 1999. Evaluation of rapidly disintegrating tablets prepared by a direct compression method. Drug Dev Ind Pharm. 25:571–581.
  • Brown D. 2003. Orally disintegrating tablets-taste over speed. Drug Dev Technol. 3:58–61.
  • Campiñez MD, Ferris C, de Paz MV, Aguilar-de-Leyva A, Galbis J, Caraballo I. 2015. A new biodegradable polythiourethane as controlled release matrix polymer. Int J Pharm. 480:63–72.
  • Committee for Medicinal Products for Human Use (CHMP). 2013. Memantine product specific bioequivalence guidance. EMA/423734/2013. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/11/WC500154318.pdf [accessed 2017 Jan 17].
  • Corveleyn S, Remon JP. 1997. Formulation and production of rapidly disintegrating tablets by lyophilisation using hydrochlorothiazide as a model drug. Int J Pharm. 152:215–225.
  • Dobetti L. 2003. Fast disintegrating tablets. US Patent No. 6, 596,311.
  • Food and Drug Administration (FDA). 2008. US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER). Guidance for Industry Orally Disintegrating Tablets. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidanc es/ucm070578.pdf [accessed 2017 Jan 17].
  • Fu Y, Yang S, Jeong SH, Kimura S, Park K. 2004. Orally fast disintegrating tablets: developments, technologies, taste-masking and clinical studies. Crit Rev Ther Drug Carrier Syst. 21:433–476.
  • Gryczke A, Schminke S, Maniruzzaman M. 2011. Development and evaluation of orally disintegrating tablets (ODTs) containing ibuprofen granules prepared by hot melt extrusion. Colloid Surf B Biointerfaces. 86:275–284.
  • Habib W, Khankari RK, Hontz J. 2000. Fast-dissolve drug delivery systems. Crit Rev Ther Drug Carrier Syst. 17:61–72.
  • ICH Expert Working Group. 2009. Pharmaceutical development Q8. ICH Harmon Tripart Guidel. 8:1–28.
  • Khan A, Iqbal Z, Rehman Z, Nasir F, Khan A, Ismail M, Roohullah, Mohammad A. 2014. Application of SeDeM expert system in formulation development of effervescent tablets by direct compression. Saudi Pharma J. 22:433–444.
  • Khan A, Iqbal Z, Ibrahim M, Nasir F, Ullah Z. 2015. Prediction of the effect of taste masking on disintegration behavior, mechanical strength and rheological characteristics of highly water soluble drug (itopride HCl): an application of SeDeM-ODT expert system. Powder Technol. 284:411–417.
  • Kuno Y, Kojima M, Ando S, Nakagami H. 2008. Effect of preparation method on properties of orally disintegrating tablets made by phase transition. Int J Pharm. 355:87–92.
  • Lindgren S, Janzon L. 1993. Dysphagia: prevalence of swallowing complaints and clinical finding. Med Clin North Am. 77:3–5.
  • Mishra DN, Bindal M, Singh SK, Vijaya Kumar SG. 2006. Spray dried excipient base: a novel technique for the formulation of orally disintegrating tablets. Chem Pharm Bull. 54:99–102.
  • Mittapelly N, Rachumallu R, Pandey G, Sharma S, Arya A, Bhatta RS, Mishra PR. 2016. Investigation of salt formation between memantine and pamoic acid: its exploitation in nanocrystalline form as long acting injection. Eur J Pharm Biopharm. 101:62–71.
  • Ofori-Kwakye K, Mfoafo KA, Kipo SL, Kuntworbe N, Boakye-Gyasi ME. 2016. Development and evaluation of natural gum-based extended release matrix tablets of two model drugs of different water solubilities by direct compression. Saudi Pharm J. 24:82–91.
  • Sastry SV, Nyshadham JR, Fix JA. 2000. Recent technological advances in oral drug delivery - a review. Pharm Sci Technol Today. 3:138–145.
  • Saurí J, Millán D, Suñé-Negre JM, Pérez-Lozano P, Sarrate R, Fàbregas A, Carrillo C, Miñarro M, Ticó JR, García-Montoya E. 2014. The use of the SeDeM diagram expert system for the formulation of Captopril SR matrix tablets by direct compression. Int J Pharm. 461:38–45.
  • Singh I, Kumar P. 2012. Preformulation studies for direct compression suitability of cefuroxime oxitil and paracetamol: a graphical presentation using SeDeM diagram. Acta Pol Pharm Drug Res. 69:87–89.
  • Stange U, Führling C, Gieseler H. 2015. Freeze drying of orally disintegrating tablets containing taste masked naproxen sodium granules in blisters. Pharm Dev Technol. 20:1018–1024.
  • Suñé-Negre JM, Carreras MR, García RF, Pérez CH, Roura RR, García-Montoya E, Carmona MM, Pérez-Lozano P, Ticó JR. 2005. Nueva metodología de preformulación galénica para la caracterización de sustancias en relación a su viabilidad para la compresión: Diagrama SeDeM. Cienc y Tecnol Pharm. 15:125–136.
  • Suñé-Negre JM, Pérez-Lozano P, Miñarro M, Roig M, Fuster R, Hernández C, Ruhí R, García-Montoya E, Ticó JR. 2008. Application of the SeDeM Diagram and a new mathematical equation in the design of direct compression tablet formulation. Eur J Pharm Biopharm. 69:1029–1039.
  • Suñé-Negre JM, García-Montoya E, Pérez-Lozano P, Aguilar-Díaz JE, Carreras MR, García RF, Carmona MM, Grau JRT. 2011. Expert systems for human, materials and automation. In: Vizureanu P, editor. SeDeM diagram: a new expert system for the formulation of drugs in solid form. ISBN: 978-953-307-334-7. InTech. http://www.intechopen.com/books/expert-systems-for-human-materials-and-automation/sedem-diagram-anew-expert-system-for-the-formulation-of-drugs-in-solid-form
  • Suñé-Negre JM, Roig M, Fuster R, Hernández C, Ruhí R, García-Montoya E, Pérez- Lozano P, Miñarro M, Ticó JR. 2014. New classification of directly compressible (DC) excipients in function of the SeDeM Diagarm Expert System. Int J Pharm. 470:15–27.
  • Thomas SJ, Grossberg GT. 2009. Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias. Clin Interv Aging. 4:367–377.
  • Virely P, Yarwood R. 1990. Zydis - a novel, fast dissolving dosage form. Manuf Chem. 61:36–37.
  • Yu DG, Branford-White C, Yang YC, Zhu LM, Welbeck EW, Yang XL. 2009. A novel fast disintegrating tablet fabricated by three-dimensional printing. Drug Dev Ind Pharm. 35:1530–1536.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.